Clinical trial
Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma
NCT05912582 is registered in ClinicalTrials.gov with Jiangsu Cancer Institute & Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma
- Lead sponsor
- Jiangsu Cancer Institute & Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 25, 2025
- Completion date
- December 25, 2028
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.